184 related articles for article (PubMed ID: 31692665)
1. Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study.
Hiyoshi M; Yano K; Nanashima A; Ikenoue M; Imamura N; Fujii Y; Hamada T; Nishida T
Ann Med Surg (Lond); 2019 Dec; 48():17-22. PubMed ID: 31692665
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Mac-2 Binding Protein Glycosylation Isomer for Prediction of Posthepatectomy Liver Failure in Patients With Hepatocellular Carcinoma.
Okuda Y; Taura K; Yoshino K; Ikeno Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Hatano E; Tanaka S; Uemoto S
Ann Surg; 2017 Jun; 265(6):1201-1208. PubMed ID: 27355265
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
[TBL] [Abstract][Full Text] [Related]
4. Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.
Eso Y; Takai A; Taura K; Takahashi K; Ueda Y; Marusawa H; Seno H
J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29473206
[TBL] [Abstract][Full Text] [Related]
5. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
8. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
Jang SY; Tak WY; Park SY; Kweon YO; Lee YR; Kim G; Hur K; Han MH; Lee WK
Ann Lab Med; 2021 May; 41(3):302-309. PubMed ID: 33303715
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma.
Ishii N; Harimoto N; Araki K; Muranushi R; Hoshino K; Hagiwara K; Gantumur D; Yamanaka T; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Shirabe K
Hepatol Res; 2019 Dec; 49(12):1398-1405. PubMed ID: 31339606
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
[TBL] [Abstract][Full Text] [Related]
13. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
[TBL] [Abstract][Full Text] [Related]
14. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
[TBL] [Abstract][Full Text] [Related]
15. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
[TBL] [Abstract][Full Text] [Related]
16. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection.
Ueda N; Kawaoka T; Imamura M; Aikata H; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Hayes CN; Yokozaki M; Chayama K
BMC Gastroenterol; 2020 Sep; 20(1):314. PubMed ID: 32977741
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
Nah EH; Cho S; Kim S; Kim HS; Cho HI
J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
[TBL] [Abstract][Full Text] [Related]
19. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
Shirabe K; Bekki Y; Gantumur D; Araki K; Ishii N; Kuno A; Narimatsu H; Mizokami M
J Gastroenterol; 2018 Jul; 53(7):819-826. PubMed ID: 29318378
[TBL] [Abstract][Full Text] [Related]
20. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
Wu PS; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
PLoS One; 2021; 16(10):e0258589. PubMed ID: 34648567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]